Literature DB >> 11444980

Kinetic studies of guinea pig liver transglutaminase reveal a general-base-catalyzed deacylation mechanism.

A Leblanc1, C Gravel, J Labelle, J W Keillor.   

Abstract

Guinea pig liver transglutaminase (TGase) reacts with 0.1 mM N-Cbz-L-Glu(gamma-p-nitrophenyl ester)Gly (5, prepared herein, K(M) = 0.02 mM) to undergo rapid acylation that can be followed spectrophotometrically at 400 nm (pH 7.0, 25 degrees C). Deacylation of the transiently formed thiolester acyl enzyme intermediate via catalytic aminolysis was studied in the presence of six primary amines of widely varying basicity (pK(NH+) = 5.6-10.5). Steady-state kinetic studies were performed to measure k(cat) and K(M) values for each amine substrate. A Brønsted plot constructed through the correlation of log(k(cat)/K(M)) and pK(NH+) for each amine substrate displays a linear free-energy relationship with a slope beta(nuc) = -0.37 +/- 0.08. The shallow negative slope is consistent with a general-base-catalyzed deacylation mechanism in which a proton is removed from the amine substrate during its rate-limiting nucleophilic attack on the thiolester carbonyl. Kinetic isotope effects were measured for four acceptor substrates (water, kie = 1.1 +/- 0.1; aminoacetonitrile, kie = 5.9 +/- 1.2; glycine methyl ester, kie = 3.4 +/- 0.7; N-Ac-L-lysine methyl ester, kie = 1.1 +/- 0.1) and are consistent with a proton in flight at the rate-limiting transition state. The active site general-base implicated by these kinetic results is believed to be His-334, of the highly conserved TGase Cys-His-Asp catalytic triad.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444980     DOI: 10.1021/bi0024097

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Identification of transglutaminase-mediated deamidation sites in a recombinant alpha-gliadin by advanced mass-spectrometric methodologies.

Authors:  Maria Fiorella Mazzeo; Beatrice De Giulio; Stefania Senger; Mauro Rossi; Antonio Malorni; Rosa Anna Siciliano
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725

2.  Hydroxamate-based colorimetric method for direct screening of transglutaminase-producing bacteria.

Authors:  Chaiwut Bourneow; Soottawat Benjakul; Aran H-Kittikun
Journal:  World J Microbiol Biotechnol       Date:  2012-02-10       Impact factor: 3.312

3.  Simultaneous analysis of enzyme structure and activity by kinetic capillary electrophoresis-MS.

Authors:  Gleb G Mironov; Christopher M Clouthier; Abdullah Akbar; Jeffrey W Keillor; Maxim V Berezovski
Journal:  Nat Chem Biol       Date:  2016-09-05       Impact factor: 15.040

4.  Deacylation transition states of a bacterial DD-peptidase.

Authors:  S A Adediran; I Kumar; R F Pratt
Journal:  Biochemistry       Date:  2006-10-31       Impact factor: 3.162

5.  Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity.

Authors:  Ellen A Rorke; Gautam Adhikary; Henryk Szmacinski; Joseph R Lakowicz; David J Weber; Raquel Godoy-Ruiz; Purushottamachar Puranik; Jeffrey W Keillor; Eric W J Gates; Richard L Eckert
Journal:  Mol Carcinog       Date:  2021-10-05       Impact factor: 4.784

6.  Structure-activity relationships of hydrophobic alkyl acrylamides as tissue transglutaminase inhibitors.

Authors:  Alana M M Rangaswamy; Pauline Navals; Eric W J Gates; Sammir Shad; Sarah K I Watt; Jeffrey W Keillor
Journal:  RSC Med Chem       Date:  2022-01-26

7.  Structure-Activity Relationships of Potent, Targeted Covalent Inhibitors That Abolish Both the Transamidation and GTP Binding Activities of Human Tissue Transglutaminase.

Authors:  Abdullah Akbar; Nicole M R McNeil; Marie R Albert; Viviane Ta; Gautam Adhikary; Karine Bourgeois; Richard L Eckert; Jeffrey W Keillor
Journal:  J Med Chem       Date:  2017-09-14       Impact factor: 7.446

Review 8.  Transglutaminase 2 inhibitors and their therapeutic role in disease states.

Authors:  Matthew Siegel; Chaitan Khosla
Journal:  Pharmacol Ther       Date:  2007-05-13       Impact factor: 12.310

9.  Transglutaminase 6: a protein associated with central nervous system development and motor function.

Authors:  Helen Thomas; Konrad Beck; Magdalena Adamczyk; Pascale Aeschlimann; Martin Langley; Radu C Oita; Lars Thiebach; Martin Hils; Daniel Aeschlimann
Journal:  Amino Acids       Date:  2011-10-08       Impact factor: 3.520

10.  Development of new scaffolds as reversible tissue transglutaminase inhibitors, with improved potency or resistance to glutathione addition.

Authors:  Kim Y P Apperley; Isabelle Roy; Vincent Saucier; Nicholas Brunet-Filion; Sara-Pier Piscopo; Christophe Pardin; Élise De Francesco; Catherine Hao; Jeffrey W Keillor
Journal:  Medchemcomm       Date:  2016-12-05       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.